Document Detail


Meniett device for Ménière's disease: use and compliance at 3 to 5 years.
MedLine Citation:
PMID:  18199955     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To review the continued use of the Meniett device 2 and 3 years after the device's initial prescription. STUDY DESIGN: Retrospective case series. SETTING: Tertiary referral center. PATIENTS: Patients fitting American Academy of Otolaryngology-Head and Neck Surgery criteria for Ménière's disease who had failed conventional medical therapy between February 2002 and April 2004 and who were ready for surgical intervention. INTERVENTION: Patients used the Meniett device as a nonsurgical alternative for Ménière's management. OUTCOME MEASURES: Continued use or non-use of the device. RESULTS: Twenty-three patients were prescribed and obtained the Meniett device in the study interval. At 2 years of minimum follow-up, there were 21 evaluable patients. Eleven patients (52%) continued to use the device and have good control of vertiginous symptoms at 2+ years. Four patients (19%) were asymptomatic at 1 year and discontinued the use of the device. Six patients (29%) had no impact on their Ménière's symptoms and stopped using the device within the first 3 months. At 3 years of minimum follow-up, there were 19 evaluable patients; of whom, 63% were either using the device or had become asymptomatic. No complications were attributable to the device. CONCLUSION: We conclude that the Meniett device is a useful minimally invasive alternative in the management of Ménière's disease. Among these patients who had failed previous medical management, 71% and 63% required no additional intervention beyond the Meniett device at a minimum of 2 and 3 years of follow-up, respectively. Most patients who failed to gain benefit did so early on in therapy.
Authors:
Douglas E Mattox; Mary Reichert
Related Documents :
2263515 - A trial with a new peripheral implanted vascular access device.
12047405 - The antibiotic-lock technique for therapy of 'highly needed' infected catheters.
8206405 - Intraperitoneal therapy administered through a groshong catheter.
1874025 - Balloon dilation treatment of phimosis in boys. report of 512 cases.
11069195 - Predicting subsequent bone density response to intermittent cyclical therapy with etidr...
19291745 - Complications of fractional co2 laser resurfacing: four cases.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology     Volume:  29     ISSN:  1531-7129     ISO Abbreviation:  Otol. Neurotol.     Publication Date:  2008 Jan 
Date Detail:
Created Date:  2008-01-17     Completed Date:  2008-02-25     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100961504     Medline TA:  Otol Neurotol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  29-32     Citation Subset:  IM    
Affiliation:
Department of Otolaryngology-Head and Neck Surgery, Emory University School of Medicine, Atlanta, Georgia 30322, USA. douglas.mattox@emoryhealthcare.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cochlear Implants* / adverse effects
Cohort Studies
Endpoint Determination
Equipment Failure
Follow-Up Studies
Humans
Meniere Disease / therapy*
Otitis Media / etiology
Patient Compliance
Recurrence
Retrospective Studies
Treatment Failure

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Congenital absence of the oval window: diagnosis, surgery, and audiometric outcomes.
Next Document:  Longitudinal results with intratympanic dexamethasone in the treatment of Ménière's disease.